Contents

Current Topics in Medicinal Chemistry, Volume 2 - Number 9

Preface

, 2(9): i

Jacques Dumas


DOI: 10.2174/1568026023393336




Prospects for Kinase Activity Modulators in the Treatment of Diabetes and Diabetic Complications

, 2(9): 915 - 938

William H. Bullock, Steven R. Magnuson, Soongyu Choi, David E. Gunn and Joachim Rudolph


DOI: 10.2174/1568026023393255




Targeting Serine / Threonine Protein Kinase B / Akt and Cell-cycle Checkpoint Kinases for Treating Cancer

, 2(9): 939 - 971

Qun Li and Gui-Dong Zhu


DOI: 10.2174/1568026023393318




Small Molecule Inhibitors of KDR (VEGFR-2) Kinase: An Overview of Structure Activity Relationships

, 2(9): 973 - 1000

Stephen J. Boyer


DOI: 10.2174/1568026023393273




Small Molecule Inhibitors of the Class 1 Receptor Tyrosine Kinase Family

, 2(9): 1001 - 1010

G. Stuart Cockerill and Karen E. Lackey


DOI: 10.2174/1568026023393309




Pyridinylimidazole Based p38 MAP Kinase Inhibitors

, 2(9): 1011 - 1020

Paul F. Jackson and James L. Bullington


DOI: 10.2174/1568026023393372




The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors

, 2(9): 1021 - 1035

Pier F. Cirillo, Christopher Pargellis and John Regan


DOI: 10.2174/1568026023393390




Recent Advances in Cyclin-Dependent Kinase Inhibition. Purine-Based Derivatives as Anti-Cancer Agents. Roles and Perspectives for the Future

, 2(9): 1037 - 1050

Jean-luc Haesslein and Nathalie Jullian


DOI: 10.2174/1568026023393291




4-Anilino-3-quinolinecarbonitriles: An Emerging Class of Kinase Inhibitors

, 2(9): 1051 - 1063

Diane H. Boschelli


DOI: 10.2174/1568026023393354




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science